PW Medtech Group Limited (HKG:1358)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.120
-0.030 (-2.61%)
Apr 29, 2026, 4:08 PM HKT
13.13%
Market Cap 1.64B
Revenue (ttm) 916.40M
Net Income (ttm) 105.02M
Shares Out 1.46B
EPS (ttm) 0.07
PE Ratio 16.11
Forward PE n/a
Dividend 0.06 (5.57%)
Ex-Dividend Date Jul 2, 2026
Volume 403,000
Average Volume 834,700
Open 1.140
Previous Close 1.150
Day's Range 1.120 - 1.150
52-Week Range 0.970 - 1.630
Beta 0.74
RSI 44.01
Earnings Date Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device... [Read more]

Sector Healthcare
Founded 1997
Employees 1,356
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1358
Full Company Profile

Financial Performance

In 2025, PW Medtech Group's revenue was 823.51 million, an increase of 7.10% compared to the previous year's 768.90 million. Earnings were 94.37 million, a decrease of -37.41%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.